<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://ir.librarynmu.com/handle/123456789/18044">
    <title>DSpace Общество:</title>
    <link>http://ir.librarynmu.com/handle/123456789/18044</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://ir.librarynmu.com/handle/123456789/19995" />
        <rdf:li rdf:resource="http://ir.librarynmu.com/handle/123456789/19967" />
        <rdf:li rdf:resource="http://ir.librarynmu.com/handle/123456789/19899" />
        <rdf:li rdf:resource="http://ir.librarynmu.com/handle/123456789/19880" />
      </rdf:Seq>
    </items>
    <dc:date>2026-09-28T15:03:13Z</dc:date>
  </channel>
  <item rdf:about="http://ir.librarynmu.com/handle/123456789/19995">
    <title>M. M. Gubergrits - a famous ukrainian clinician to the 140th anniversary of his birth</title>
    <link>http://ir.librarynmu.com/handle/123456789/19995</link>
    <description>Название: M. M. Gubergrits - a famous ukrainian clinician to the 140th anniversary of his birth
Авторы: Klymenko, L.
Краткий осмотр (реферат): Marko Moiseyevich Gubergrits (1886-1851), academician of the Academy of Sciences of the Ukrainian SSR (1949), honored scientist of the Ukrainian SSR (1935), organizer of health care and higher medical school, was a famous clinician in the scientific environment of domestic medicine of Ukraine in the first half of the 20th century. M.M. Gubergrits was born in January 1886 in the city of Dorpat (now Tartu, Estonia) in the family of a doctor.</description>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://ir.librarynmu.com/handle/123456789/19967">
    <title>Пам’яті педагога – фізіолога Світлани Миколаївни Бєлан (до 90-річчя зі дня народження)</title>
    <link>http://ir.librarynmu.com/handle/123456789/19967</link>
    <description>Название: Пам’яті педагога – фізіолога Світлани Миколаївни Бєлан (до 90-річчя зі дня народження)
Авторы: Виноградова-Аник, О. О.; Лук’яненко, І. А.
Краткий осмотр (реферат): Статтю присвячено науковій, педагогічній та методологічній діяльності доцента кафедри фізіології Національного медичного університету імені О.О. Богомольця С.М. Бєлан, яка була однією з ключових фігур у реформуванні української медичної освіти. Її внесок полягав в інтеграції медичної освіти України в європейський освітній простір та запровадженні ліцензійних інтегрованих іспитів «Крок», які стали гарантією якості, міжнародної сумісності та конкурентної спроможності вітчизняної медичної освіти. Майже п’ятдесят років трудової діяльності С.М. Бєлан пов’язано з НМУ і кафедрою фізіології. Колектив кафедри фізіології Національного медичного університету вшановує пам’ять Світлани Миколаївни Бєлан в 90-ту річницю зі дня її народження і завдячує їй за підготовку цілої плеяди висококваліфікованих викладачів – фізіологів, науковців і студентів, у подальшому практичних лікарів різних спеціальностей.</description>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://ir.librarynmu.com/handle/123456789/19899">
    <title>Surgical clinic for the treatment of tuberculous exudative pleurisy: availability of anti-tuberculosis medicines</title>
    <link>http://ir.librarynmu.com/handle/123456789/19899</link>
    <description>Название: Surgical clinic for the treatment of tuberculous exudative pleurisy: availability of anti-tuberculosis medicines
Авторы: Shapovalova, V.; Dovzhuk, V.; Dovzhuk, N.
Краткий осмотр (реферат): Introduction. Tuberculous exudative pleurisy remains a complex clinical problem for surgical practice, especially in&#xD;
wartime, logistical disorders, and limited access to medicines. The peculiarities of the course of the disease,&#xD;
difficulties in diagnosis, and the need for invasive verification methods cause delays in diagnosis and treatment. The&#xD;
effectiveness of pharmacotherapy largely depends not only on the pharmacological properties of anti-tuberculosis&#xD;
drugs, but also on the stability of their availability in the pharmaceutical market. Purpose. To assess the availability of&#xD;
anti-tuberculosis drugs in Ukraine's pharmaceutical market using clinical content analysis technology, to ensure&#xD;
continuous pharmacotherapy for patients with tuberculous exudative pleurisy in surgical clinics. Materials and&#xD;
methods. The study was conducted from 2022 to 2026. The object of the study was anti-tuberculosis drugs in&#xD;
circulation in Ukraine. Clinical content analysis technology, based on the principles of evidence-based medicine,&#xD;
evidence-based pharmacy, and clinical and pharmacological analysis, was used. data processing (Sturgess formula), as&#xD;
well as regulatory, documentary, marketing, and graphic research methods. Results. The presence of 41 names of&#xD;
anti-tuberculosis drugs on the pharmaceutical market of Ukraine has been established. 4 groups of manufacturers have&#xD;
been identified based on the breadth of their range and the stability of their supply. It has been found that most drugs&#xD;
have confirmed quality of production (GMP) and bioequivalence, but there are some gaps in the availability of fixed&#xD;
combinations and pediatric forms. It has been proven that the continuity of pharmacotherapy depends on the&#xD;
availability of alternative manufacturers, the variety of dosage forms, and the stability of supply. Discussion. Content&#xD;
analysis as an innovative tool allows you to systematize information about medicines and relate it to clinical needs.&#xD;
The results obtained emphasize the importance of organizational support of treatment, including the formation of&#xD;
formularies, procurement planning, and ensuring the continuity of therapy. Particular attention should be paid to the&#xD;
risk of pharmacokinetic alterations associated with pleural localization, which may affect treatment effectiveness. Conclusions. Clinical technology of content analysis is an effective tool for assessing the availability of anti- tuberculosis drugs and optimizing pharmacotherapy for tuberculous exudative pleurisy. The need to provide at least two alternative manufacturers for each active ingredient and the availability of fixed combinations to increase adherence to treatment and prevent interruption of therapy have been determined. forms and procurement planning in health care institutions.</description>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://ir.librarynmu.com/handle/123456789/19880">
    <title>The Role Of Early-Life Microbiota Programming And Age-Related Neuroendocrine Homeostasis Remodeling In The Modulation Of Cognitive Aging</title>
    <link>http://ir.librarynmu.com/handle/123456789/19880</link>
    <description>Название: The Role Of Early-Life Microbiota Programming And Age-Related Neuroendocrine Homeostasis Remodeling In The Modulation Of Cognitive Aging
Авторы: Rusalov, V.; Lagodych, T.; Lukianenkom, I.; Lazarеnko, V.
Краткий осмотр (реферат): The role of early life microbiome programming and age related neuroendocrine homeostasis remodeling in the development of cognitive aging is considered. Current data on the influence of the gut brain axis, intestinal microbiota, neuroinflammation, insulin resistance, and hormonal changes on neuroplasticity, the functional state of the central nervous system, and the development of neurodegenerative processes are summarized. It is shown that early dysbiosis, impairment of the intestinal barrier function, chronic low grade systemic inflammation, and age related deficiency of neuroprotective hormones may represent important factors contributing to cognitive decline and the acceleration of neurodegenerative changes during aging.</description>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

